AEON Biopharma Inc.

NASDAQ: AEON · Real-Time Price · USD
0.80
0.02 (2.56%)
At close: Aug 15, 2025, 3:59 PM
0.80
-0.62%
After-hours: Aug 15, 2025, 07:50 PM EDT

AEON Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
146.67M 72.99M 61.34M 52.31M -116.2M -51.96M -37.99M -24.95M -9.91M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
169.12M 42.01M 24.54M 13.08M -185.6M -78.02M -62.64M -45M -10.44M
Net Income
169.12M 42.01M 24.54M 13.08M -185.6M -78.02M -62.64M -45M -10.44M
Selling & General & Admin
12.12M 13.64M 15.96M 16.76M 18.94M 16.73M 11.78M 7.94M 2.44M
Research & Development
9.27M 14.18M 20.17M 28.4M 33.49M 35.24M 26.21M 17.01M 7.48M
Other Expenses
-168.07M -100.81M -97.46M -97.46M 63.77M n/a n/a n/a n/a
Operating Expenses
-146.67M -72.98M -61.34M -52.3M 116.2M 51.96M 37.99M 24.95M 9.91M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-146.67M -72.98M -61.34M -52.3M 116.2M 51.96M 37.99M 24.95M 9.91M
Income Tax Expense
n/a n/a n/a -16.58K -39.46K -66.55K -66.55K -49.96K -27.08K
Shares Outstanding (Basic)
3.98M 554.26K n/a 539.49K 37.27M 380.98K 22M n/a 22M
Shares Outstanding (Diluted)
3.98M 555.34K n/a 539.49K 37.27M 380.98K 22M n/a 22M
EPS (Basic)
309.88 79.73 35.60 34.80 -269.04 -41.64 -1.27 -0.47 -0.47
EPS (Diluted)
309.87 79.72 35.60 34.80 -269.04 -41.64 -1.27 -0.47 -0.47
EBITDA
-21.3M -27.73M -36.03M -45.06M -52.33M -51.88M -37.94M -24.91M -9.91M
EBIT
-21.39M -27.82M -36.13M -45.16M -52.43M -51.96M -37.99M -24.95M -9.91M
Depreciation & Amortization
91K 97K 97K 97K 105K 107.08K 84.08K 59.08K 27.08K